High-dose thoracic radiation therapy at 3.0 gy/fraction in Inoperable stage I/II non-small cell lung cancer

Japanese Journal of Clinical Oncology

Volumn 38, Issue 2, 2008, Pages 92-98

  Kim, BoKyong ^a,b   Ahn, Yong Chan ^a   Lim, Do Hoon ^a   Nam, Hee Rim ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Dankook University College of Medicine   (South Korea)

Author keywords

Non small cell lung cancer; Radiation therapy

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INOPERABLE CANCER; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; METASTASIS; MORBIDITY; PHOTON THERAPY; PROGNOSIS; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIATION SAFETY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 40349083694     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym159     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures. American Cancer Society; 2004.
2. Graham PH, Gebski VJ, Langlands AO. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1995;31: 261-6.
3. Noordijk EM, vd Poest Clement E, Hermans J, Wever AM, Leer JW. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 1988;13:83-9.
4. Zhang HX, Yin WB, Zhang LJ, Yang ZY, Zhang ZX, Wang M, et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 1989;14:89-94.
5. Beattie EJ, Raskin NM. Progress in lung cancer: Non-oat cell (non-small cell lung cancer). Jpn J Surg 1987;17:313-22.
6. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22.
7. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
8. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 2002;121:1155-8.
9. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): A systematic review. Thorax 2001;56:628-38.
10. Kim BK, Ahn YC, Lim DH, Park SW. Definitive high dose thoracic irradiation by 3.0 Gy fraction size in stage III non-small cell lung cancer. J Lung Cancer 2004;3:16-23.
11. Koukourakis M, Hlouverakis G, Kosma L, Skarlatos J, Damilakis J, Giatromanolaki A, et al. The impact of overall treamtnet time on the results of radiotherapy for nonsmall cell lung carcinoma. Int J Radiat Oncol Biol Phys 1996;34:315-22.
12. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-54.
13. Lagerwaard FJ, Senan S, van Meerbeeck JP, Graveland WJ. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? Radiother Oncol 2002;63: 151-7.
14. Willner J, Baier K, Caragiani E, Tschammler A, Flentje M. Dose, volume, and tumor control prediction in primary radiotherapy of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52: 382-9.
15. Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi AT, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999;24:31-7.
16. Thirion P, Holmberg O, Collins CD, O'Shea C, Moriarty M, Pomeroy M, et al. Escalated dose for non-small cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiother Oncol 2004;71:163-6.
17. Shimizu S, Shirato H, Ogura S, Akita-Dosaka H, Kitamura K, Nishioka T, et al. Detection of lung tumor movement in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:304-10.
18. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
19. Hiraoka M, Matsuo Y, Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiother 2007;11:32-5.
20. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63: 1010-5.
21. Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, et al. A randomized phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial. Radiother Oncol 1999;52:129-36.
22. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomized multicentre trial. CHART Steering committee. Radiother Oncol 1999;52:137-48.
23. Bentzen S, Saunders MI, Dische S, Parmar MK. Updated data for CHART in NSCLC: Further analyses. Radiother Oncol 2000;55:86-7.
24. Chang JY, Roth JA. Stereotactic body radiation therapy for stage I non-small cell lung cancer. Thorac Surg Clin 2007;17:251-9.